Endoscopic radiofrequency ablation or surveillance in patients with Barrett&apos;s oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial

Esophagus Diseases

Optimizing Management of Patients with Barrett's Esophagus and Low-grade or No Dysplasia Based On Comparative Modeling: Optimizing Barrett's esophagus management

Clin Gastroenterol Hepatol.

Omidvari AH, Ali A, Hazelton WD, Kroep S, Lee M, Naber SK, Lauren BN, Ostvar S, Richmond E, Kong CY, Rubenstein JH, Lansdorp-Vogelaar I, Luebeck G, Hur C, Inadomi J

doi: 10.1016/j.cgh.2019.11.058.

Esophagus Diseases

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial

Lancet.

Jankowski JAZ, de Caestecker J, Love SB, Reilly G, Watson P, Sanders S, Ang Y, Morris D, Bhandari P, Attwood S, Ragunath K, Rameh B, Fullarton G, Tucker A, Penman I, Rodgers C, Neale J, Brooks C, Wise A, Jones S, Church N, Gibbons M, Johnston D, Vaidya K, Anderson M, Balata S, Davies G, Dickey W, Goddard A, Edwards C, Gore S, Haigh C, Harding T, Isaacs P, Jackson L, Lee T, Lim PL, Macdonald C, Mairs P, McLoughlin J, Monk D, Murdock A, Murray I, Preston S, Pugh S, Smart H, Soliman A, Todd J, Turner G, Worthingon J, Harrison R, Barr H, Moayyedi P

doi: 10.1016/S0140-6736

Esophagus Diseases

Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study

Gut.

Sami SS, Ravindran A, Kahn A, Snyder D, Santiago J, Ortiz-Fernandez-Sordo J, Tan WK, Dierkhising RA, Crook JE, Heckman MG, Johnson ML, Lansing R, Ragunath K, di Pietro M4, Wolfsen H, Ramirez F, Fleischer D, Wang KK, Leggett CL, Katzka DA, Iyer PG

doi: 10.1136/gutjnl-2018-317513.

Esophagus Diseases

Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period

Gut

van Munster S, Nieuwenhuis E, Weusten BLAM, Alvarez Herrero L, Bogte A, Alkhalaf A, Schenk BE, Schoon EJ, Curvers W, Koch AD, van de Ven SEM, de Jonge PJF, Tang TJ, Nagengast WB, Peters FTM, Westerhof J, Houben MHMG, Bergman JJ, Pouw RE, Dutch Barrett Expert Centers.

doi: 10.1136/gutjnl-2020-322615

Esophagus Diseases

Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus after Endoscopic Therapy

Clin Gastroenterol Hepatol.

Eluri S, Earasi AG, Moist SE, Dellon ES, Shaheen NJ

doi: 10.1016/j.cgh.2019.04.065.

Esophagus Diseases

Emerging optical methods for endoscopic surveillance of Barrett's oesophagus

Lancet Gastroenterol Hepatol.

Waterhouse DJ, Fitzpatrick CRM, di Pietro M, Bohndiek SE

doi: 10.1016/

Inflammatory Bowel Disease

Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

BMC Gastroenterol.

Snowden JA, Hawkey C, Hind D, Swaby L, Mellor K, Emsley R, Mandefield L, Lee E, Badoglio M, Polge E, Labopin M, Gribben J, Pockley AG, Foulds GA, Lobo A, Travis S, Parkes M, Satsangi J, Papaioannou D, Lindsay JO, Autologous Stem Cell Transplantation In Refractory CD - Low Intensity Therapy Evaluation Study Investigators., European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP)

doi: 10.1186/s12876-019-0992-2.

ColonoscopyGastrointestinal Cancer

Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial

Lancet Gastroenterol Hepatol

Ishikawa H, Mutoh M, Sato Y, Doyama H, Tajika M, Tanaka S, Horimatsu T, Takeuchi Y, Kashida H, Tashiro J, Ezoe Y, Nakajima T, Ikematsu H, Hori S, Suzuki S, Otani T, Takayama T, Ohda Y, Mure K, Wakabayashi K, Sakai T

doi: 10.1016/S2468-1253(21)00018-2

ColonoscopyInflammatory Bowel Disease

Multicentre randomised controlled trial on virtual chromoendoscopy in the detection of neoplasia during colitis surveillance high-definition colonoscopy (the VIRTUOSO trial)

Gut

Kandiah K, Subramaniam S, Thayalasekaran S, Chedgy FJ, Longcroft-Wheaton G, Fogg C, Brown JF, Smith SC, Iacucci M, Bhandari P

doi: 10.1136/gutjnl-2020-320980

Gastroenterology

Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial

Related content

Optimizing Management of Patients with Barrett's Esophagus and Low-grade or No Dysplasia Based On Comparative Modeling: Optimizing Barrett's esophagus management

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial

Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study

Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period

Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus after Endoscopic Therapy

Emerging optical methods for endoscopic surveillance of Barrett's oesophagus

Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial

Multicentre randomised controlled trial on virtual chromoendoscopy in the detection of neoplasia during colitis surveillance high-definition colonoscopy (the VIRTUOSO trial)